Allergy to class/drug
Pediatric patients <15 yo
Type 1 diabetes
DKA
Active bladder cancer
CHF (symptomatic; NYHA Class III-IV)
CHF (NYHA Class I-II)
CHF Risk
Edema
Hepatic impairment
Bladder cancer history
Premenopausal anovulatory patients
Pioglitazone
Glyburide
Metformin
Glipizide
Fenofibrate
Gemfibrozil
Intralipid
Aliskiren